
Pegfilgrastim Biosimilar Market to Reach USD 9.3 Billion by 2035, Driven by Rising Oncology Treatments
The globalĀ pegfilgrastim biosimilar marketĀ is on a strong growth trajectory, fueled by increasing demand for cost-effective biologics in oncology, rising cancer prevalence, and broader adoption of supportive care therapies. Valued at …
Pegfilgrastim Biosimilar Market to Reach USD 9.3 Billion by 2035, Driven by Rising Oncology Treatments Read More